Multicenter Study of the Accuracy of the BD MAX™ MDR-TB Assay for Detection of Mycobacterium tuberculosis Complex and Mutations Associated with Resistance to Rifampin and Isoniazid
28 September 2019
The BD MAX MDR-TB assay had high sensitivity and specificity for detection of MTB, and RIF and INH drug resistance and may be an important tool for rapid detection of TB and MDR-TB globally.
Further reading: Clinical Infectious Diseases
Author(s): Maunank Shah, Sonia Paradis, Joshua Betz, Natalie Beylis, Renu Bharadwaj, Tatiana Caceres, Eduardo Gotuzzo, Moses Joloba, Vidya Mave, Lydia Nakiyingi, Mark P Nicol, Neeta Pradhan, Bonnie King, Derek Armstrong, Deborah Knecht, Courtney E Maus, Charles K Cooper, Susan E Dorman, Yukari C Manabe
Effective Surveillance Healthy Patients
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!